PBH - CIK 0001295947
Prestige Consumer Healthcare Inc. trades as PBH and has a market capitalization of $2.33 B, making it the #1990 largest US-listed company by market value. In its fiscal 2026 annual report the company posted revenue of $1.09B, down 4.3% from the prior year and net income of $190.30M. This page tracks Prestige Consumer Healthcare Inc. through 1,235 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Prestige Consumer Healthcare Inc.'s revenue grew from $882.06M to $1.09B, a compound annual growth rate of 2.4%. Net profit margin expanded from 7.9% to 17.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Annual report | 10-K | 2026-05-14 |
| Insider trade (amended) | 4/A | 2026-05-14 |
| Major company event | 8-K | 2026-05-13 |
| Insider trade | 4 | 2026-05-12 |
| Insider sale notice | 144 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
TARRYTOWN, N.Y. , May 18, 2026 /PRNewswire/ -- The most meaningful trips aren't defined by the destination, but by the purpose behind them. Dramamine ® , the #1 brand for nausea relief, is encouraging travelers to tune in to the 'why' behind their journeys with the debut of the ' Your Why. Your Way. ' campaign. Whether seeking adventure or challenging themselves to go somewhere new, Dramamine ® invites people to embrace traveling with purpose knowing that its selection of nausea solutions won't let nausea stand in the way of the experiences that matter most.
Reported revenues of $281.6 million in Q4 and $1,088.7 million in fiscal year 2026
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com . To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
Entered agreement to acquire a portfolio of brands with revenue of $200 million and EBITDA of $95 million
The largest companies sharing Prestige Consumer Healthcare Inc.'s SEC industry classification (pharmaceutical preparations).
Prestige Consumer Healthcare Inc. (PBH) has a market capitalization of $2.33 B as of 2026-06-10, ranking #1990 among US-listed companies.
Prestige Consumer Healthcare Inc. reported revenue of $1.09B for fiscal year 2026, a decrease of 4.3% year over year.
Yes. Prestige Consumer Healthcare Inc. reported net income of $190.30M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
Diluted EPS of $0.97 in Q3 and Adjusted Diluted EPS of $1.14 , versus prior year Q3 Diluted EPS of $1.22